How Do I Get Approval to Sell Medical Devices in France?

Getting approval to sell medical devices in France requires obtaining CE marking and completing ANSM registration with the French National Agency for Medicines and Health Products Safety. You’ll need an Authorized Representative if your company isn’t based in the EU, along with proper quality management systems and device classification. The process involves both Europe-wide compliance and France-specific requirements that work together to ensure market access.

What Are the Basic Requirements to Sell Medical Devices in France?

France requires medical device manufacturers to meet four essential requirements for market entry:

• CE marking compliance – Demonstrates conformity with European Medical Device Regulation (MDR) requirements through technical documentation, risk management files, and clinical evaluation reports that prove your device meets safety and performance standards
• ANSM registration – Creates a direct relationship with French health authorities by providing essential information about your device, manufacturing processes, and local representation, enabling authorities to track devices and respond to safety concerns
• Authorized Representative designation – Establishes a local point of contact for French authorities who handles regulatory communications, supports incident reporting, and assists with field safety corrective actions when needed
• ISO 13485 quality management systems – Maintains certification that demonstrates your commitment to quality management systems specifically designed for medical device manufacturing

These four pillars work together to form the foundation of French medical device market entry, ensuring compliance with both European and national regulations. CE marking serves as your passport to the European market including France, while ANSM registration enables French authorities to effectively monitor and regulate devices within their national healthcare system. Your Authorized Representative must be clearly identified on device labeling and acts as the crucial link between your company and French regulatory authorities throughout the entire market lifecycle.

How Does the ANSM Approval Process Actually Work?

The ANSM approval process follows a structured pathway with distinct phases:

• Device classification determination – Establishes whether your device follows Class I self-declaration procedures or requires Class IIa, IIb, or III notified body involvement, directly impacting approval timelines and documentation requirements
• Technical file preparation – Involves assembling comprehensive documentation including device descriptions, intended use statements, risk analysis reports, clinical evaluation data, and labeling information that demonstrate safety and performance
• Authorized Representative designation – Ensures you have qualified local representation to facilitate communication between your company and ANSM throughout the review process
• Formal application submission – Requires submitting complete technical dossiers through ANSM’s electronic systems with applicable fees and readiness to respond to requests for additional information
• ANSM review and assessment – Involves regulatory evaluation based on device risk classification, with higher-risk devices receiving more intensive scrutiny and longer review periods

This systematic approach ensures thorough evaluation while providing clear milestones for manufacturers to track their progress. ANSM conducts its review based on device risk classification, with each class requiring different levels of documentation and assessment intensity. Your Authorized Representative plays a crucial role throughout this process by ensuring smooth information exchange, prompt responses to regulatory queries, and maintaining compliance with French-specific requirements that complement the broader European regulatory framework.

What’s the Difference Between CE Marking and ANSM Registration for France?

CE marking and ANSM registration serve complementary but distinct regulatory functions:

• CE marking scope and function – Operates at the European level to demonstrate compliance with Medical Device Regulation essential requirements through technical documentation, clinical evaluation, and risk management, providing access to all European markets including France
• ANSM registration purpose – Functions as France’s national oversight layer, providing authorities with detailed information about devices, manufacturers, and local representatives to enable targeted market surveillance and rapid safety response
• Assessment processes – CE marking involves conformity assessment procedures that may require notified body involvement depending on device classification, while ANSM registration focuses on national regulatory oversight and market surveillance capabilities
• Compliance requirements – CE marking is mandatory for all device classes seeking European market access, whereas ANSM registration requirements vary by device classification and specific risk levels

These two regulatory systems work together rather than operating independently to ensure comprehensive market oversight. Your CE marking satisfies European regulatory requirements and serves as the foundation for market access, while ANSM registration ensures French authorities can effectively monitor, regulate, and respond to issues with devices within their national healthcare system. Both are typically required for complete market access, though specific requirements depend on your device classification and intended distribution strategy, making it essential to understand how these complementary systems support your overall regulatory compliance strategy.

How Long Does It Take to Get Approval to Sell Medical Devices in France?

Approval timelines vary significantly based on device classification and several key factors:

• Class I devices (2-4 months) – Follow self-declaration procedures without notified body involvement, with timelines primarily dependent on technical documentation preparation, Authorized Representative designation, and ANSM registration completion
• Class IIa and IIb devices (6-12 months) – Require notified body assessment involving third-party review of technical documentation, quality management systems, or both, depending on specific classification rules
• Class III devices (12-18 months) – Face the longest timelines due to comprehensive notified body involvement, extensive clinical evidence requirements, and detailed ANSM review processes for these high-risk devices
• Preparation and documentation quality – Well-prepared applications with complete, high-quality documentation move through the process more efficiently, while incomplete submissions face delays and additional review cycles
• Regulatory complexity factors – Novel technologies, complex clinical evidence requirements, or unique regulatory situations can extend timelines beyond standard expectations

Several proven strategies can help expedite your approval process while maintaining compliance standards. Engaging experienced regulatory consultants early ensures documentation completeness and regulatory strategy optimization, while working with established In-Country Representatives who understand ANSM procedures can streamline communication and reduce delays. Additionally, conducting pre-submission meetings with ANSM helps clarify requirements and identify potential issues before formal application submission, ultimately saving time and resources throughout the approval process.

How MedEnvoy Global Helps with French Medical Device Approval

Successfully navigating French medical device approval requires understanding both European and national requirements while maintaining focus on documentation quality and regulatory relationships. MedEnvoy Global provides comprehensive solutions to streamline this complex process through:

• Expert Authorized Representative services – Serving as your qualified local contact with deep knowledge of ANSM procedures and French regulatory requirements
• Complete regulatory documentation support – Ensuring your technical files meet both CE marking and ANSM registration standards while avoiding common submission delays
• Strategic timeline management – Optimizing approval pathways based on your device classification and market entry goals
• Ongoing compliance monitoring – Maintaining regulatory standing throughout your device lifecycle with proactive surveillance and reporting

Let us handle the regulatory complexities of French market entry so you can focus on innovation and growing your business. Contact MedEnvoy Global today to discuss your French medical device approval strategy.

Related Articles

• Do I Need a Mexican Representative for Medical Devices?
• Can I use my EUDAMED data for Swissdamed?
• What happens if I miss the EUDAMED deadline?
• What is a Swiss Authorized Representative for Medical Devices?
• What Testing Is Required for Mexico Medical Device Registration?